Finally, recent studies in patients with congenital dyserythropoietic anemia type II (CDAII) uncovered mutations in the SEC23B gene revealing its essential role in erythrocyte lineage development. The gene discussed is SEC23B; the disease is congenital dyserythropoietic anemia type 2.